81 results match your criteria: "University of Massachusetts Chan School of Medicine.[Affiliation]"
Association between parity and markers of inflammation: The multi-ethnic study of atherosclerosis.
Front Cardiovasc Med
September 2022
Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Introduction: Multiparity has been associated with increased risk of cardiovascular disease (CVD). Inflammation may be a mechanism linking parity to CVD. We investigated the association between parity and later-life markers of inflammation.
View Article and Find Full Text PDFLessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia report.
Ann N Y Acad Sci
December 2022
Bill & Melinda Gates Foundation, Seattle, Washington, USA.
Article Synopsis
- - The COVID-19 pandemic revealed the world's unpreparedness, prompting a symposium titled "Lessons from the Pandemic" where experts discussed insights from COVID-19 and other viral outbreaks.
- - Participants included researchers from academia, industry, government, and nonprofits, focusing on the successes and challenges faced during the pandemic.
- - A consensus emerged that ongoing investments in healthcare infrastructure, collaborations, and diagnostic capabilities, particularly in low-to-middle income countries, are crucial for effective responses to future zoonotic disease threats.
Randomised controlled trial evaluating the effects of screening and referral for social determinants of health on Veterans' outcomes: protocol.
BMJ Open
September 2022
National Center for PTSD, VA Boston Healthcare System, Boston, Massachusetts, USA.
Introduction: Health policy leaders recommend screening and referral (S&R) for unmet social needs (eg, food) in clinical settings, and the American Heart Association recently concluded that the most significant opportunities for reducing cardiovascular disease (CVD) death and disability lie with addressing the social determinants of CVD outcomes. A limited but promising evidence base supports these recommendations, but more rigorous research is needed to guide health care-based S&R efforts. Funded by the Veteran Health Administration (VA), the study described in this paper will assess the efficacy of S&R on Veterans' connections to new resources to address social needs, reduction of unmet needs and health-related outcomes (adherence, utilisation and clinical outcomes).
View Article and Find Full Text PDFPsoriasis and hidradenitis suppurativa are associated with inflammatory bowel disease: a growing body of evidence.
Br J Dermatol
November 2022
Department of Dermatology, University of Massachusetts Chan School of Medicine, Worcester, MA, USA.
A Controlled Study in CPR-Survival in Propensity Score Matched Full-Code and Do-Not-Resuscitate ICU Patients.
J Intensive Care Med
October 2022
George Washington University School of Medicine, Washington, DC, USA.
Background: Cardiopulmonary Resuscitation (CPR) causes significant injuries and increased cost among transiently resuscitated patients that do not survive their hospitalizations. Descriptive studies show zero and near-zero percent survival for CPR recipients with high Apache II scores. Despite these factors, no controlled studies exist in CPR to guide patient selection for CPR candidacy.
View Article and Find Full Text PDFDevelopment and implementation of a prescription opioid registry across diverse health systems.
JAMIA Open
July 2022
Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Objective: Develop and implement a prescription opioid registry in 10 diverse health systems across the US and describe trends in prescribed opioids between 2012 and 2018.
Materials And Methods: Using electronic health record and claims data, we identified patients who had an outpatient fill for any prescription opioid, and/or an opioid use disorder diagnosis, between January 1, 2012 and December 31, 2018. The registry contains distributed files of prescription opioids, benzodiazepines and other select medications, opioid antagonists, clinical diagnoses, procedures, health services utilization, and health plan membership.